USANA Health Sciences (NYSE:USNA - Get Free Report) was downgraded by equities research analysts at Sidoti from a "strong-buy" rating to a "hold" rating in a research note issued to investors on Tuesday,Zacks.com reports.
Other equities research analysts also recently issued research reports about the company. StockNews.com downgraded USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. DA Davidson upped their target price on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a "neutral" rating in a research report on Thursday, January 2nd.
Check Out Our Latest Research Report on USANA Health Sciences
USANA Health Sciences Stock Up 3.2 %
USNA stock traded up $1.01 during trading on Tuesday, hitting $32.79. The company had a trading volume of 175,484 shares, compared to its average volume of 134,370. The firm has a 50-day moving average price of $33.81 and a 200-day moving average price of $36.73. USANA Health Sciences has a 12 month low of $30.13 and a 12 month high of $50.32. The stock has a market cap of $624.98 million, a price-to-earnings ratio of 11.59, a PEG ratio of 0.93 and a beta of 0.87.
Institutional Trading of USANA Health Sciences
Several institutional investors and hedge funds have recently made changes to their positions in USNA. Martingale Asset Management L P boosted its position in shares of USANA Health Sciences by 2.1% in the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company's stock worth $634,000 after purchasing an additional 340 shares during the last quarter. KBC Group NV lifted its stake in USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company's stock valued at $40,000 after buying an additional 519 shares during the period. R Squared Ltd bought a new position in USANA Health Sciences during the fourth quarter worth about $28,000. Safe Harbor Fiduciary LLC acquired a new position in shares of USANA Health Sciences during the 3rd quarter worth about $30,000. Finally, Exchange Traded Concepts LLC increased its stake in shares of USANA Health Sciences by 11.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company's stock valued at $308,000 after acquiring an additional 869 shares during the last quarter. Institutional investors own 54.25% of the company's stock.
About USANA Health Sciences
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
